Dr. Leonard Schleifer, president & CEO of Regeneron Pharmaceuticals, offers insight on EYLEA, which is used to treat macular degeneration -- the leading cause of blindness in elderly.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT